AMTX
Price
$1.20
Change
-$0.07 (-5.51%)
Updated
Oct 22 closing price
Capitalization
86.6M
14 days until earnings call
Intraday BUY SELL Signals
GEVO
Price
$1.14
Change
+$0.03 (+2.70%)
Updated
Oct 22 closing price
Capitalization
281.85M
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMTX vs GEVO

AMTX vs GEVO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMTX vs. GEVO commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMTX is a StrongBuy and GEVO is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AMTX with price predictions
Oct 22, 2026

AMTX in +2.10% Uptrend, advancing for three consecutive days on October 16, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AMTX advanced for three days, in 193 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

AMTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMTX as a result. In 72 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

The Moving Average Convergence Divergence Histogram (MACD) for AMTX turned negative on September 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 32 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.

AMTX moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMTX crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for AMTX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. AMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.269) is normal, around the industry mean (2.359). P/E Ratio (-1.395) is within average values for comparable stocks, (-17.286). AMTX's Projected Growth (PEG Ratio) (19.780) is very high in comparison to the industry average of (1.548). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.555) is also within normal values, averaging (48.960).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

A.I.Advisor
a Summary for GEVO with price predictions
Oct 22, 2026

GEVO's RSI Oscillator is staying in oversold zone for 6 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where GEVO advanced for three days, in 188 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

GEVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

GEVO moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GEVO crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for GEVO entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.032) is normal, around the industry mean (2.359). P/E Ratio (-1.267) is within average values for comparable stocks, (-17.286). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (2.012) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. GEVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

FUNDAMENTALS RATINGS
AMTX vs GEVO: Fundamental Ratings
AMTX
GEVO
OUTLOOK RATING
1..100
5420
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8798
PRICE GROWTH RATING
1..100
9087
P/E GROWTH RATING
1..100
2215
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GEVO's Valuation (37) in the Chemicals Specialty industry is somewhat better than the same rating for AMTX (95). This means that GEVO’s stock grew somewhat faster than AMTX’s over the last 12 months.

GEVO's Profit vs Risk Rating (100) in the Chemicals Specialty industry is in the same range as AMTX (100). This means that GEVO’s stock grew similarly to AMTX’s over the last 12 months.

AMTX's SMR Rating (87) in the Chemicals Specialty industry is in the same range as GEVO (98). This means that AMTX’s stock grew similarly to GEVO’s over the last 12 months.

GEVO's Price Growth Rating (87) in the Chemicals Specialty industry is in the same range as AMTX (90). This means that GEVO’s stock grew similarly to AMTX’s over the last 12 months.

GEVO's P/E Growth Rating (15) in the Chemicals Specialty industry is in the same range as AMTX (22). This means that GEVO’s stock grew similarly to AMTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMTXGEVO
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (AMTX: $1.27 vs. GEVO: $1.11)
Brand notoriety: AMTX and GEVO are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: AMTX: 224% vs. GEVO: 50%
Market capitalization -- AMTX: $86.6M vs. GEVO: $281.85M
AMTX [@Chemicals: Specialty] is valued at $86.6M. GEVO’s [@Chemicals: Specialty] market capitalization is $281.85M. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $50 to $235.27B. The average market capitalization across the [@Chemicals: Specialty] industry is $11.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMTX’s FA Score shows that 1 FA rating(s) are green while GEVO’s FA Score has 1 green FA rating(s).

  • AMTX’s FA Score: 1 green, 4 red.
  • GEVO’s FA Score: 1 green, 4 red.
According to our system of comparison, GEVO is a better buy in the long-term than AMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMTX’s TA Score shows that 4 TA indicator(s) are bullish while GEVO’s TA Score has 4 bullish TA indicator(s).

  • AMTX’s TA Score: 4 bullish, 6 bearish.
  • GEVO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GEVO is a better buy in the short-term than AMTX.

Price Growth

AMTX (@Chemicals: Specialty) experienced а -11.19% price change this week, while GEVO (@Chemicals: Specialty) price change was -5.13% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +0.09%. For the same industry, the average monthly price growth was -4.67%, and the average quarterly price growth was -5.75%.

Reported Earning Dates

AMTX is expected to report earnings on Nov 05, 2026.

GEVO is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Chemicals: Specialty (+0.09% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

View a ticker or compare two or three
AMTX
Daily Signal:
Gain/Loss:
GEVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMTX has been loosely correlated with GEVO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if AMTX jumps, then GEVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMTX
1D Price
Change %
AMTX100%
-5.51%
GEVO - AMTX
42%
Loosely correlated
+2.70%
LWLG - AMTX
35%
Loosely correlated
-6.77%
DINO - AMTX
31%
Poorly correlated
-2.59%
PARR - AMTX
31%
Poorly correlated
-5.34%
CLNE - AMTX
31%
Poorly correlated
+3.70%
More

GEVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEVO has been loosely correlated with AMTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GEVO jumps, then AMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEVO
1D Price
Change %
GEVO100%
+2.70%
AMTX - GEVO
42%
Loosely correlated
-5.51%
ASPI - GEVO
40%
Loosely correlated
-3.69%
RPC - GEVO
38%
Loosely correlated
+4.60%
SSL - GEVO
28%
Poorly correlated
+7.84%
GPRE - GEVO
28%
Poorly correlated
-1.77%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WBIG26.970.29
+1.09%
WBI BullBear Yield 3000 ETF (WBIG)
XLRI22.170.11
+0.49%
State Street Real Estate Select Sector SPDR Premium Income ETF (XLRI)
ICOW42.91-0.05
-0.12%
Pacer Developed Markets International Cash Cows 100 ETF (ICOW)
HDUS72.68-0.77
-1.05%
Hartford Disciplined US Equity ETF (HDUS)
FXZ74.61-2.39
-3.10%
First Trust Materials AlphaDEX Fund (FXZ)